PubMed:10212389
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 319-359 | cell_line | denotes | human promyelocytic leukemia HL-60 cells |
| T2 | 413-435 | protein | denotes | retinoic acid receptor |
| T3 | 437-440 | protein | denotes | RAR |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-47 | Sentence | denotes | Dicarba-closo-dodecaboranes as a pharmacophore. |
| S2 | 48-94 | Sentence | denotes | Retinoidal antagonists and potential agonists. |
| S3 | 95-222 | Sentence | denotes | Synthesis and biological evaluation of the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids are described. |
| S4 | 223-360 | Sentence | denotes | Their retinoidal activity were examined in terms of the differentiation-inducing ability toward human promyelocytic leukemia HL-60 cells. |
| S5 | 361-560 | Sentence | denotes | High retinoidal activity (agonist or antagonist for retinoic acid receptor (RAR) requires a carboxylic acid moiety and an appropriate hydrophobic group located at a suitable position on the molecule. |
| S6 | 561-714 | Sentence | denotes | The 4-carboranyl-substituted compounds (7, 11) showed antagonistic activity but no agonistic activity even in the presence of the potent synergist HX630. |
| S7 | 715-847 | Sentence | denotes | On the other hand, the 3-carboranyl-substituted compounds (8, 12) showed potential agonistic activity, but no antagonistic activity. |
| S8 | 848-960 | Sentence | denotes | The results indicates that carboranes are applicable as the hydrophobic moiety of biologically active molecules. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-27 | NP | denotes | Dicarba-closo-dodecaboranes |
| C2 | 134-207 | NP | denotes | the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids |
| C3 | 223-228 | NP | denotes | Their |
| C4 | 875-885 | NP | denotes | carboranes |
| R1 | C3 | C2 | coref-pron | Their,the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids |
| R2 | C4 | C1 | coref-ident | carboranes,Dicarba-closo-dodecaboranes |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-27 | other_organic_compound | denotes | Dicarba-closo-dodecaboranes |
| T2 | 33-46 | other_name | denotes | pharmacophore |
| T3 | 48-70 | other_organic_compound | denotes | Retinoidal antagonists |
| T4 | 75-93 | other_organic_compound | denotes | potential agonists |
| T5 | 144-170 | other_organic_compound | denotes | dicarba-closo-dodecaborane |
| T6 | 172-181 | other_organic_compound | denotes | carborane |
| T7 | 198-207 | other_organic_compound | denotes | retinoids |
| T8 | 319-359 | cell_line | denotes | human promyelocytic leukemia HL-60 cells |
| T9 | 413-435 | protein_family_or_group | denotes | retinoic acid receptor |
| T10 | 437-440 | protein_family_or_group | denotes | RAR |
| T11 | 453-475 | other_organic_compound | denotes | carboxylic acid moiety |
| T12 | 483-512 | other_organic_compound | denotes | appropriate hydrophobic group |
| T13 | 565-599 | other_organic_compound | denotes | 4-carboranyl-substituted compounds |
| T14 | 601-602 | other_organic_compound | denotes | 7 |
| T15 | 604-606 | other_organic_compound | denotes | 11 |
| T16 | 691-707 | other_name | denotes | potent synergist |
| T17 | 708-713 | other_organic_compound | denotes | HX630 |
| T18 | 738-772 | other_organic_compound | denotes | 3-carboranyl-substituted compounds |
| T19 | 774-775 | other_organic_compound | denotes | 8 |
| T20 | 777-779 | other_organic_compound | denotes | 12 |
| T21 | 798-816 | other_name | denotes | agonistic activity |
| T22 | 825-846 | other_name | denotes | antagonistic activity |
| T23 | 908-926 | other_organic_compound | denotes | hydrophobic moiety |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 339-347 | HP_0001909 | denotes | leukemia |